2015 (Impact Factor: 57.8)

    1. Cerasa A*. Machine Learning on Parkinson’s disease? Let’s translate into clinical practice. Journal of Neuroscience Methods 2016; 266:161-2. [IF=2.55].
    1. Cerasa A*, Castiglioni I, Salvatore C, Funaro A, Martino I, Alfano S, Donzuso G, Perrotta P, Gioia MC, Gilardi MC, Quattrone A. Biomarkers of eating disorders using support vector machine analysis of structural neuroimaging data: preliminary results. Behav Neurol 2015: doi: 10.1155/2015/924814 [IF= 1.31].
    2. Cerasa A, Quattrone A. Linking Essential Tremor to the Cerebellum – Neuroimaging Evidence. Cerebellum 2016; 15: 263-275 [IF= 3.23].
    3. Dalla Volta R, Fasano F, Cerasa A, Mangone G, Quattrone A, Buccino G. Walking indoors, walking outdoors: an fMRI study. Frontiers in Psychology 2015; 6:1502. doi: 10.3389/fpsyg.2015.01502 [IF= 2.32].
    4. Bono F, Salvino D, Cerasa A, Vescio B, Nigro S, Quattrone A. Electrophysiological and structural MRI correlates of dystonic head rotation in drug-naïve patients with torticollis. Parkinsonism and Related Disorders 2015; 21(12):1415-20 [IF= 4.48].
    5. Riccelli R, Passamonti L, Cerasa A, Nigro S, Cavalli S, Chiriaco C, Valentino P, Nisticò R, Quattrone A. Individual differences in depression are associated with abnormal function of the limbic system in multiple sclerosis patients. Multiple Sclerosis J 2015; doi: 10.1177/1352458515606987 [IF= 4.84].
    6. Salvatore C, Cerasa A, Battista P, Gilardi MC, Quattrone A, Castiglioni I. Magnetic Resonance Imaging biomarkers for the early diagnosis of Alzheimer’s Disease: a machine learning approach. Frontiers in Neuroscience 2015; 9:307. doi: 10.3389/fnins.2015.00307 [IF= 3.56].
    7. Cerasa A, Donzuso G, Morelli M, Mangone G, Salsone M, Passamonti L, Augimeri A, Arabia G, Quattrone A. The motor inhibition system in Parkinson’s disease with levodopa-induced dyskinesias. Movement Disorders 2016; 30(14): 1912-1920 [IF=7.07].
    8. Sarica A, Cerasa A§*, Quattrone A. The neurocognitive profile of cerebellum in Multiple Sclerosis. International Journal of Molecular Sciences 2015; 16(6): 12185-12198 [IF=3.22].
    9. Cerasa A*§, Koch G, Fasano A and Morgante F. Future scenarios for levodopa-induced dyskinesias in Parkinson’s disease. Frontiers in Neurology; 6:76. DOI: 10.3389/fneur.2015.00076 [IF=3.55].
    10. Weier K, Banwell B, Cerasa A, Collins DL, Dogonowski, AN, Lassmann H, Quattrone A, Sahraian MA, Siebner HR, Sprenger T. Consensus paper: The role of the cerebellum in multiple sclerosis. Cerebellum 2015; 14(3) 364-374 [IF= 3.23].
    11. Cerasa A*, Quattrone A. The effectiveness of cognitive treatment in patients with Parkinson’s disease: a new phase for the neuropsychological rehabilitation. Parkinsonism and Related Disorders 2015; 21(2):165 [IF= 4.48].
    12. Cerasa A*§, Koch G, Donzuso G, Mangone G, Morelli M, Brusa L, Stampanoni Bassi M , Ponzo V, Picazio S, Passamonti L, Salsone M, Augimeri A, Caltagirone C, Quattrone A. A network centred on the inferior frontal cortex is critical for inducing levodopa-induced dyskinesias. Brain 2015; 138 (2): 414-427 [IF= 10.3].